In Figure 6 we illustrate that intrinsically aggressive subtypes of localized breast cancer, such as triple-negative or HER2 positive, have significantly higher levels of serum leptin compared to less aggressive subtypes such as luminal. This evidence concerns the gene LEP and breast carcinoma.